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ABSTRACT The fungal cell wall is a critically important structure that represents a
permeability barrier and protective shield. We probed Candida albicans and Crypto-
coccus neoformans with liposomes containing amphotericin B (AmBisome), with or
without 15-nm colloidal gold particles. The liposomes have a diameter of 60 to
80 nm, and yet their mode of action requires them to penetrate the fungal cell wall
to deliver amphotericin B to the cell membrane, where it binds to ergosterol. Sur-
prisingly, using cryoﬁxation techniques with electron microscopy, we observed that
the liposomes remained intact during transit through the cell wall of both yeast spe-
cies, even though the predicted porosity of the cell wall (pore size, ~5.8 nm) is theo-
retically too small to allow these liposomes to pass through intact. C. albicans mu-
tants with altered cell wall thickness and composition were similar in both their in
vitro AmBisome susceptibility and the ability of liposomes to penetrate the cell wall.
AmBisome exposed to ergosterol-deﬁcient C. albicans failed to penetrate beyond the
mannoprotein-rich outer cell wall layer. Melanization of C. neoformans and the ab-
sence of amphotericin B in the liposomes were also associated with a signiﬁcant re-
duction in liposome penetration. Therefore, AmBisome can reach cell membranes in-
tact, implying that fungal cell wall viscoelastic properties are permissive to vesicular
structures. The fact that AmBisome can transit through chemically diverse cell wall
matrices when these liposomes are larger than the theoretical cell wall porosity sug-
gests that the wall is capable of rapid remodeling, which may also be the mecha-
nism for release of extracellular vesicles.
IMPORTANCE AmBisome is a broad-spectrum fungicidal antifungal agent in which
the hydrophobic polyene antibiotic amphotericin B is packaged within a 60- to
80-nm liposome. The mode of action involves perturbation of the fungal cell mem-
brane by selectively binding to ergosterol, thereby disrupting membrane function.
We report that the AmBisome liposome transits through the cell walls of both Can-
dida albicans and Cryptococcus neoformans intact, despite the fact that the liposome
is larger than the theoretical cell wall porosity. This implies that the cell wall has de-
formable, viscoelastic properties that are permissive to transwall vesicular trafﬁc.
These observations help explain the low toxicity of AmBisome, which can deliver its
payload directly to the cell membrane without unloading the polyene in the cell
wall. In addition, these ﬁndings suggest that extracellular vesicles may also be able
to pass through the cell wall to deliver soluble and membrane-bound effectors and
other molecules to the extracellular space.
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The fungal cell wall is a complex matrix of polysaccharides and proteins that arealmost universally absent in mammalian cells. For this reason, they are excellent
speciﬁc targets for existing antifungal drugs, such as the echinocandins, and the focus
of much research looking for novel antifungal agents. For most fungi, the wall is a
layered structure, with the inner cell wall being composed of a core, largely conserved
laminate of -glucans and chitin that establishes the strength and physical shape of the
wall and the outer wall being more species speciﬁc in nature (1, 2). In Candida albicans,
the outer cell wall is enriched with a ﬁbrillar layer of highly glycosylated mannoproteins
which have important roles in deﬁning physical properties such as hydrophobicity and
porosity as well as adhesive and immunologic characteristics (3, 4). In Aspergillus
fumigatus, the outer wall has less protein but includes two bioactive polysaccharides,
galactomannan and galactosaminoglycan, while in Cryptococcus species, the outer wall
is surrounded by a thick capsule composed of glucuronoxylomannan (GXM) and
galactoxylomannan (GalXM). The Candida mannoprotein ﬁbrillar layer and the Crypto-
coccus capsule are also protective barriers against host enzymes and microbicides and
act to impair macrophage phagocytosis and recognition of the underlying -1,3-glucan
layer that is a strong activator of myeloid cell secretion of inﬂammatory cytokines (2, 5).
The fungal cell wall is absolutely essential for the viability and ecology of all fungi, and
as such, it is one of the most complex and highly regulated structures in the microbial
world.
Recent studies have focused on the composition, as well as the biochemical and
immunologic aspects, of fungal cell walls; however, new imaging and analytic tech-
nology platforms are beginning to reveal novel biophysical and structural aspects of
the cell wall that are likely to prove critical to our understanding of these structures.
Sample preparation techniques for transmission electron microscopy (TEM), such as
high-pressure freezing followed by freeze-substitution (HPF-FS), have enabled us to
visualize unprecedented architectural details such as the structure of the Candida
mannoprotein ﬁbrils (6, 7) and Cryptococcus capsule (1, 8) and the presence of mem-
brane vesicles within the cell wall matrix (9, 10). The presence of such vesicles begs an
explanation as to how such large vesicles transit from the membrane through the wall
to the external ﬂuid around a cell.
In C. albicans and other yeasts, including Saccharomyces cerevisiae, a number of
approaches have been taken to measure the cell wall porosity. Studies using the
high-molecular-weight polysaccharide inulin estimated that the interspace volume of
the yeast wall is 23 to 33% of the total volume, suggesting that the wall is an open,
porous structure (11). Several studies indicate that the outer mannoprotein layer of
yeast determines wall porosity, and porosity assays based on measurement of cell lysis
due to DEAE-dextran, poly-L-lysine, and glucanase suggest that molecules with a
hydrodynamic radius up to 5.8 nm, equivalent to a molecular radius (Mr) of 400,000 Da,
are able to permeate the wall (12, 13). It is also known that the secretome, which
contains many large glycoproteins such as invertase and other enzymes (up to
200,000 Da), is able to pass through the yeast cell wall (14).
AmBisome, the ﬁrst antifungal agent licensed for the treatment of systemic fungal
infections (15, 16), must pass through the fungal cell wall to reach the fungal cell
membrane, where it binds with ergosterol to produce membrane leakiness (17). It is a
polyene macrolide antibiotic produced by the bacterium Streptomyces nodosus and is
one of very few broad-spectrum chemotherapeutic agents available for the treatment
of systemic fungal infections. A side effect of treatments using native amphotericin B as
an emulsion with deoxycholate is an associated nephrotoxicity that usually requires
speciﬁc management using diuretics (18–21). Subsequently, a variety of lipid formula-
tions have been devised that signiﬁcantly mitigate the unwanted clinical side effects of
amphotericin B treatment (21). Of the three lipid formulations in clinical practice,
AmBisome is the least toxic (22, 23) and is widely used as a treatment of choice, in
particular in cases where empirical treatment is required for suspected fungal
infection and the agent of disease is not known (24). Some lipid formulations of
amphotericin B present the polyene macrolide in a carrier planar lipid sheet or
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fragment, but AmBisome is the only lipid carrier in which the antibiotic is encap-
sulated within the liposome membrane bilayer of an intact liposome (17, 18, 23, 25).
AmBisome is effective in the treatment of a wide range of fungal diseases caused
by Candida, Aspergillus, and Cryptococcus species and by Mucorales and other rare
pathogens (24).
The estimates of cell wall porosity all suggest that there should be no porosity
barrier to free amphotericin B (molecular weight, 923.49) but that an AmBisome
liposome, or a cell wall vesicle, would be too large to freely permeate the cell wall. For
these reasons, we wondered whether AmBisome would be able to transit the cell wall
intact or whether, as might be predicted, it would dissociate within the wall prior to
delivering amphotericin B to the cell membrane. We show here that the liposomes
containing AmBisome pass through the cell wall layers of both C. albicans and Cryp-
tococcus neoformans intact and that the intact AmBisome can deliver inelastic 15-nm
colloidal gold particles, which are above the ~6-nm theoretical hydrodynamic radius of
freely permeating molecules, through the cell wall. These observations suggest a new
paradigm for how molecular trafﬁcking through the fungal cell wall is regulated and
suggest that AmBisome could be used as a ﬂexible carrier for the delivery of a wide
variety of reagents through a wide range of nonporous cell walls. Furthermore, the
results have important implications for our understanding of cell wall rigidity and
porosity and the mechanisms by which extracellular vesicles are released by fungal cells
into the surrounding space.
RESULTS
AmBisome transits intact through the C. albicans and C. neoformans cell wall.
Electron-dense, sphere-shaped AmBisome liposomes could be resolved throughout the
inner and outer cell wall layers of C. albicans using freeze-substitution transmission
electron microscopy (Fig. 1). In section, these particles were 20 to 60 nm in most
sections, smaller on average than the diameter of the native liposome, perhaps due to
shrinkage occurring during sample preparation and because some sections were not
medial to the liposome. In tomograms of the C. albicans wall, intact liposomes could be
readily seen in the inner and outer cell wall layers (see Movies S1 and S2 in the
supplemental material). The tomograms, which capture multiple images, displayed
full-size liposomes. Liposome particles were also seen intact at the surface of the
plasma membrane but not within the cytoplasm of the cell. No such particles were
observed in any liposome controls lacking AmBisome (Fig. S1a) or in cells that were
treated with 12 g/ml amphotericin B deoxycholate preparations (Fig. S1b). No accu-
mulation of AmBisome was observed at the outer cell wall surface or at the base of the
microﬁbrillar layer.
AmBisome carries gold particles to the cell membrane. Because the AmBisome
liposomes are larger than the estimates of 5.8 nm for the maximum hydrodynamic
radius of particles that could diffuse through the cell wall, we wished to test whether
the liposomes deformed as they passed through the sieve of polysaccharides in the cell
wall. We used liposomes that had encapsulated 15-nm-diameter colloidal gold particles
within the liposome lumen and liposomes that had smaller, 1.6-nm gold particles
associated with the outside of the liposome bilayer. Remarkably, both types of gold-
labeled liposomal particles could be observed throughout the cell walls of C. albicans
and C. neoformans (Fig. 2a to e and 3). Since it is not feasible that the 15-nm gold
particles could deform as they passed through the mesh of the cell wall during transit,
this implies that the liposomes displaced polysaccharide chains of the cell wall around
them as they moved through the wall. As controls, 15-nm gold particles, devoid of a
liposomal carrier, were also used. These were unable to enter either the outer or inner
cell wall layers of C. albicans (Fig. 2f and g) or the capsule of C. neoformans (not shown).
AmBisome therefore facilitated the delivery of the gold particles through the mass of
the C. albicans cell wall. Images of both encapsulated C. neoformans (Fig. 3a, b, e, f, and
i) and an acapsular mutant of C. neoformans (Fig. 3c, d, g, h, and j) also showed
liposomes within the capsule layer and within the subcapsular inner cell wall. Therefore,
AmBisome Transit through Fungal Cell Walls ®
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the AmBisome liposomes could penetrate the cell wall and capsule layers, apparently
intact, of two phylogenetically distant fungal species, which are known to differ in cell
wall architecture and composition.
Liposomes lacking amphotericin B fail to enter the inner cell wall. When
liposomes that had the same lipid composition as AmBisome but were devoid of
amphotericin B were used, they were observed at the base of the ﬁbrils of the outer cell
wall of C. albicans, but they did not, or very rarely, entered the inner -glucan–chitin
layer (Fig. 4a to c). For C. neoformans, liposomes containing amphotericin B were
observed embedded inside the fungal cell wall, often in close proximity to the plasma
membrane, whereas liposomes without amphotericin B were excluded from entering
the cell wall or were maintained at the exterior cell wall perimeter (not shown).
Melanized C. neoformans cells, which have a considerably less porous cell wall than
nonmelanized cells (26), were more resistant to amphotericin B-liposome transit
through the cell wall, with a few liposomes transiting partially through the wall and no
membrane-adjacent liposomes observed (Fig. 3i and k).
Cell wall transit of AmBisome is altered in ergosterol-deﬁcient Candida mu-
tants. We next tested whether the transit of the liposomes would be altered if they
were exposed to ergosterol-deﬁcient Candidamutants. C. albicans erg3-1 and erg11 null
mutants had signiﬁcantly elevated MICs for AmBisome (4 and16 g/ml, respectively),
compared to 0.5 g/ml for the wild-type parent strain SC5314. When AmBisome was
FIG 1 TEM images of C. albicans SC5314 incubated with 12 g/ml AmBisome, showing intact liposomes
in the outer (a, c, and d) and inner (a, b, c, and e) cell wall and at the cell membrane (f), indicated by
arrows. The granular particles in the cytoplasm are ribosomes, not liposomes. Bars, 100 nm.
Walker et al. ®
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incubated with the erg3-1 or erg11 mutant, the liposomes were observed to concen-
trate at the junction between the outer ﬁbrillar and inner cell wall layers (Fig. 4d and
e). Similarly, when an erg3/erg11 double null mutant of Candida tropicalis was used, the
AmBisome MIC increased from 1 to 16 g/ml and the liposomes again failed to enter
the inner cell wall layer and remained concentrated at the base of the outer cell wall
microﬁbrils (images not shown).
AmBisome affects cell wall porosity. Since AmBisome liposomes seemed to be
able to transit through cell walls with a porosity that was predicted to exclude them,
we next tested whether AmBisome affected the measured cell wall porosity of C. al-
bicans using a standard porosity assay based on assessing the relative speed of
FIG 2 TEMs of cell walls of wild-type C. albicans SC5314 cells revealing AmBisome liposomes encapsu-
lating 15-nm-diameter colloidal gold particles (a to c) or AmBisome liposomal membrane studded with
1.6-nm gold particles (d and e). Control gold unencapsulated particles failing to enter the outer or inner
cell walls are shown in panels f and g. Bars, 100 nm. The cartoon icons with orange spheres represent
AmBisome liposomes, and the gold spheres represent 15-nm or 1.6-nm gold particles that were either
encapsulated inside the liposome or present within the liposomal membrane, respectively. These
liposomal reagents were imaged in the indicated panels.
AmBisome Transit through Fungal Cell Walls ®
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penetration of two detergents with different molecular weights and their ability to
cause cell lysis. In this assay, a short, 1-h exposure was used, at which time no
measurable decrease in cell viability was observed by plating of viable cells on yeast
extract-peptone-dextrose (YPD) agar, but the apparent relative porosity of the cell wall
increased 5 times in the presence of AmBisome (Fig. 5a).
Mutations in cell walls of C. albicans do not alter AmBisome sensitivity.We then
examined a range of C. albicans cell wall mutants that we knew were altered in cell wall
thickness or in their chitin or mannan content and assessed whether these mutations
altered their sensitivity to AmBisome and the transit of AmBisome through the cell wall
(images not shown). The mnt1Δ/mnt2Δ, pmr1Δ, and och1Δ glycosylation mutants had
reduced thickness in the outer cell wall microﬁbrillar layer, and the mnt1Δ/mnt2Δ and
pmr1Δ mutants also had a thinner inner layer (Table 1). The och1Δ mutant is known to
activate the Mkc1-dependent cell wall salvage mitogen-activated protein kinase (MAPK)
pathway, resulting in a thickened cell wall due to the upregulation of chitin synthesis
(27) (Table 1). The chs3 mutant lacks 80 to 90% of wild-type cell wall chitin. None of
these mutants had major differences in their 50% inhibitory concentrations (IC50s) for
AmBisome at 24-h and 48-h time points, although the IC50 of the och1Δ mutant was
slightly elevated and the chs3Δ mutant had a slightly reduced IC50 (Table 1; Fig. 5b). To
FIG 3 Distribution of AmBisome-encapsulated gold particles (a to d and i to k) or gold-only unencapsulated 1.4-nm gold
particles (e to h) relative to the cell wall and capsule of wild-type (H99) C. neoformans, an acapsular mutant (Cap67), and a
melanin-deﬁcient mutant (Mel H99). Bars, 100 nm. Cy, cytoplasm; CW, cell wall; Ca, capsule. The colored cartoon icons are
liposomal reagents as described in the legend to Fig. 1.
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determine the susceptibility of these cell wall mutants to AmBisome at an earlier time
point, the CFU of each mutant after exposure to AmBisome for 6 h and 24 h was
determined. At 6 h, the pmr1 and chs3 mutants were more susceptible to AmBisome;
however, by 24 h there was no difference in susceptibility to AmBisome for any of the
mutant strains (Fig. 5b). Therefore, although there were no substantial differences in
MIC in the mutants, the mutant with the increased chitin content (och1) was slightly
more resistant and the chs3 mutant with reduced chitin content was slightly more
sensitive to AmBisome (Fig. 5b). Chitin may be somewhat of a retardant to AmBisome
cell wall penetration, given these mild effects on AmBisome MIC. However, based on
electron microscopy, there were no obvious differences in AmBisome distribution, as
the liposomes were seen transiting throughout the cell wall of each mutant (not
shown). The results indicate that AmBisome can penetrate through the cell wall despite
signiﬁcant differences in cell wall composition.
DISCUSSION
In this study, we used liposomes containing amphotericin B (AmBisome) with or
without 15-nm colloidal gold particles to investigate the fate of these vesicles during
their interaction with cells of two fungal species that differ in their cell wall structure.
To our surprise, liposomes penetrated the cell walls of both C. albicans and C. neofor-
FIG 4 Liposomes with no incorporated amphotericin B (a to c) and an erg3-1 mutant (d) and erg11 mutant (e) of
C. albicans with AmBisome, both showing a deﬁciency in entering the inner cell wall layer. Bars, 100 nm.
AmBisome Transit through Fungal Cell Walls ®
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mans, structures that are often considered rigid and not porous enough for such large
particles. This observation has important implications for (i) the mechanism of AmBi-
some antifungal action, (ii) the potential usefulness of developing liposomes to deliver
cargo to fungal cells, and (iii) our views on fungal cell porosity, viscoelastic properties,
and extracellular vesicle transport.
AmBisome has been used clinically in the treatment of fungal infections for more
than 25 years, and yet the details of exactly how this drug induces cell death remain to
be fully elucidated. Although it has long been assumed that the fungicidal properties
FIG 5 (a) Assay of the relative porosity of the cell wall of wild-type (WT) C. albicans SC5314 in the
presence and absence of 12 g/ml AmBisome. Error bars are standard deviations (n  3). (b) Relative
killing of C. albicans CAI-4 (wild type) and a range of null mutants with deletions in cell wall synthesis
genes at a low concentration (0.5 g/ml) of AmBisome to show relative inhibition due to various
perturbations in cell wall composition after 6 h and 24 h. The error bars are standard deviations (n  3);
asterisks show signiﬁcant differences from control (P  0.05).
TABLE 1 Mean thickness of C. albicans cell wall, measured in 10 TEM medial sections, in
comparison with sensitivity to AmBisome measured at 24 h and 48 h
Strain
AmBisome IC50
(g/ml) at time: Cell wall thickness (nm)  SDa
24 h 48 h Outer wall Inner wall
Wild type 1 2 77  15 76  17
pmr1Δ mutant 0.5 1 46  9 56  23
och1Δ mutant 2 4 6  0.8 230  29
mnn4Δ mutant 0.5 2 79  9 77  23
mnt1Δ/mnt2Δ mutant 1 1 34  5 50  17
chs3Δ mutant 0.25 0.5 81  20 42  9
aThe outer wall refers to the mannoprotein ﬁbrillar fringe, and the inner wall refers to the glucan-chitin
amorphous layer.
Walker et al. ®
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of amphotericin B are due to its ability to form membrane channels, it has been
suggested more recently that amphotericin B can kill yeast cells by binding membrane
ergosterol without forming a channel and that channel formation can be a secondary
effect that potentiates the toxicity of this polyene (28), which also stimulates the
formation of oxygen radicals (29). Whatever the mechanism or mechanisms, this agent
is membrane active and therefore must transit the cell wall of the fungus in order to
deliver the amphotericin B to the fungal sterol target in the cell membrane.
AmBisome liposomes contain cholesterol, which contributes to the stability of the
liposomes. It is included not to promote fusion but to help retain the amphotericin B
in the liposomes until the liposomes bind to the fungal cell wall. The liposomes traverse
the fungal cell wall until they come into direct contact with ergosterol. Amphotericin
B in the liposomes has a 10-fold-higher afﬁnity for ergosterol than cholesterol, resulting
in the release of amphotericin B from the liposomes to interact with the ergosterol in
the fungal cell membrane.
Fungal cell walls differ substantially in their cell wall composition, and so it is at one
level remarkable that amphotericin B in its liposomal formulation is still among the
broadest-spectrum agents available to the clinician. AmBisome liposomes are large in
relation to the porosity of the meshwork of polysaccharide chains that compose the
bulk of the fungal cell wall, and therefore, it is not clear if they have to disassemble in
order for the AmBisome liposome to transit the wall to reach the cell membrane. Some
current views of the mechanism of action of AmBisome suggest that these liposomes
ﬁrst bind to cell walls and then dissociate, freeing amphotericin B to travel alone
through the cell wall to reach the cell membrane and produce its toxic effects (18). Our
data show that AmBisome liposomes seem to migrate through the cell wall intact and
discharge their toxic payload only when they reach the inner side of the cell wall at the
surface of the hydrophobic membrane. Although there are other liposomal amphoter-
icin B formulations, which have the same or different lipid components, these formu-
lations do not have AmBisome’s efﬁcacy and decreased toxicity proﬁle (22, 23, 30), and
thus, the observations reported here cannot be extrapolated to these other liposomal
amphotericin B formulations.
We have also shown that the ability of intact AmBisome liposomes to reach the
membrane seems to require the presence of amphotericin B itself, since liposomes that
are devoid of the polyene were not able to transit the inner cell wall layer (Fig. 6). The
amphotericin B in AmBisome binds with the cholesterol in the liposome bilayer and
spans the entire liposome bilayer, forming a pore. When not in contact with a
FIG 6 Cartoon summarizing the patterns of distribution of AmBisome liposomes and liposomes carrying
gold particles. The outer mannoprotein layer of the cell wall of C. albicans is shown as the blue fork-like
structure. The cartoon icons with orange spheres represent AmBisome liposomes, and the gold spheres
represent 15-nm or 1.6-nm gold particles that were either encapsulated inside the liposome or present
within the liposomal membrane, respectively. The light orange sphere represents a liposome devoid of
amphotericin B, and the orange wall of the right hand side represents an ergosterol-deﬁcient mutant.
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fungus, the amphotericin B in AmBisome remains associated with the liposome
bilayer, resulting in decreased mammalian cell toxicity (20). Thus, because ampho-
tericin B in AmBisome is not hidden within the bilayer, it is allowed to interact with
the ergosterol when it comes in close proximity to it since its afﬁnity for ergosterol
is 10 times higher than its afﬁnity for cholesterol in the liposome bilayer (23). In
mutants of C. albicans that were ergosterol deﬁcient, we observed that liposomes
accumulated at the base of the microﬁbrils and did not penetrate further into the
cell wall (Fig. 6). This may suggest that some ergosterol resides in the cell wall and
acts to mediate the transit of AmBisome through the cell wall. Fungal cell walls are
known to contain lipid (31–33), possibly as a result of extracellular vesicle transit,
and these vesicles will include ergosterol in their membranes (10).
This mode of action of AmBisome with different fungal species helps to explain its
broad antifungal activity since it allows AmBisome to target sites of intracellular or
extracellular fungal infection without causing host cell toxicity. The liposome initially
binds with the fungal cell wall (15, 34) and releases its amphotericin B at the fungal cell
membrane only after it transits intact through the cell wall. Since liposomes were not
observed in the cytoplasm, liposome dissociation probably occurs at the plasma
membrane. Evidence for the intracellular targeting of AmBisome to Candida was
observed when AmBisome or free amphotericin B was used to treat Candida infection
in Langerhans cells. TEM results showed killing of the yeast by both forms of the drug
but no damage to the host cell with AmBisome and extensive damage to the host cell
with the free drug. Tissue histopathology of extracellular Aspergillus infection also has
shown minimal tissue damage with AmBisome accompanied by signiﬁcant reduction of
the fungal burden (35).
The ﬁnding that liposomes containing colloidal gold particles penetrated the cell
wall suggests that this system may be adapted to deliver certain cargoes to fungal cells.
For example, nucleic acids and other drugs could be packaged in AmBisome-type
liposomes to enhance their delivery to fungal cells. The ability of the liposomes
containing colloidal gold to penetrate the cell wall was a surprise because this structure
is often perceived as a rigid and tough barrier, with a much smaller porosity than the
diameter of the liposomes. However, it is important to remember that some of our
notions of rigid cell walls that come from the analysis of cell walls isolated by chemical
treatments (e.g., zymosan) are inappropriate because they bear little resemblance to
living structures. Instead, our observations imply that the cell wall is a dynamic
structure with ﬂexible viscoelastic properties. This view is not surprising if one considers
how rapidly yeast cells can bud and transform into hyphae and other tip-growing cell
types, actions that show the cell wall as a dynamic structure capable of rapid change.
There is precedent that even larger structures can cross the fungal cell wall from the
outside, given that bacteria have been reported to invade fungal cells by crossing the
cell wall to form endosymbionts (36). The fact that the fungal cell wall can be easily
rearranged during morphogenesis combined with observations that it can be easily
penetrated by bacteria and liposomes suggests that we should rethink this structure as
being more akin to a porous and malleable barrier rather than being a rigid structure
with low porosity.
The observation that AmBisome liposomes can traverse the cell wall also has
important implications for the mechanism(s) for the release of extracellular vesicles (37).
Bacterial (38) and fungal species, including C. albicans and C. neoformans, have now
been shown to produce extracellular vesicles, which often carry virulence-related cargo
(10, 39, 40). High-resolution electron microscopy has shown vesicles in the cell wall (31),
implying that these are released to the extracellular space after cell wall transit. The fact
that liposomes can penetrate into the cell wall provides strong support for the notion
that a similar mechanism exists in the reverse direction such that vesicles produced by
the fungal cell and released at the level of the cell membrane ﬁnd their way to the
extracellular space by direct cell wall transit.
A major question posed by the penetration of the cell wall by AmBisome liposomes
is whether some motive force is required for cell wall transport. The fact that liposomes
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devoid of amphotericin B do not transit the cell wall indicates that something more
than this particular liposomal structure is needed for this phenomenon. It is reasonable
to assume that some motive force other than diffusion or Brownian motion will be
needed for such large structures to cross the cell wall with directionality. One possibility
noted above is that the amphotericin B in AmBisome liposomes binds to ergosterol
present in the cell wall and liposomes are then transported inward through an existing
motive mechanism for vesicular reshufﬂing. Further support for a motive mechanism in
the cell wall comes from cell wall melanin, since melanin is believed to be synthesized
in fungal melanosomes that are then transported to the cell wall (41, 42). Consistent
with this, melanin “ghosts” isolated from melanized cells have been reported to contain
considerable amounts of lipid (43). Since cell wall-associated melanin is constantly
remodeled during fungal cell morphogenesis and budding, there must exist mecha-
nisms for moving melanosomes, which in turn could be appropriated by AmBisome
liposomes for cell wall transit. Addressing the mechanism that propels cell wall transit
is an important area for future studies.
Only the chitin content of the cell wall had a signiﬁcant effect on the AmBisome MIC,
and only melanin, and to a lesser extent chitin, seemed to act as a retardant to
AmBisome transit through the cell wall. The melanized cell wall of C. neoformans was
considerably less permeable to transit by liposomes containing colloidal gold than that
of nonmelanized cells. Fungal cell wall melanization involves a process where melanin
granules are covalently cross-linked to polysaccharides, including chitin (44), a process
that is expected to increase rigidity. Progressive melanization is also accompanied by
reduced porosity (26, 45). The combination of increased cross-linking and reduced
porosity, which are not necessarily independent, could make the melanized cell wall
less permeable to liposomes and reduce the susceptibility of melanized C. neoformans
to AmBisome. In this regard, melanized fungal cells are known to be less susceptible to
amphotericin B (46).
In summary, colloidal gold liposomal particles, combined with electron microscopy,
have the potential to be useful tools for studying the fungal cell wall and manipulating
the growth of fungi. Using this approach, we found that AmBisome liposomes, includ-
ing those carrying colloidal gold particles, can cross the fungal cell wall, and this has
important implications for our notions of cell wall structure and mechanisms of
AmBisome drug delivery. These observations that liposomes can migrate through the
cell wall provide insights into how fungal exosomes may transit through the wall into
the extracellular space (37). Like most exciting scientiﬁc ﬁndings, this observation raises
more questions than it answers, which in turn suggest new avenues for inquiry. For
example, perturbing the system by changing temperature and liposomal lipid compo-
sition, combined with colloidal gold electron microscopy, could produce additional
insights to understand this phenomenon. In this regard, fungal cells are susceptible to
AmBisome at 35°C or at room temperature but not at 4°C, while free amphotericin B is
active across a wide range of temperatures (47). In light of our observations, temper-
ature effects on transport across the cell wall are another variable to be considered in
interpreting such ﬁndings. Finally, it is possible that liposomes could be engineered to
carry nonpermeant drugs, antibodies, or enzymes in the liposome lumen in order to
deliver them to the fungal cytosol through the otherwise impermeable fungal cell wall.
MATERIALS AND METHODS
Strains, mutants, and growth conditions. C. albicans strains were maintained on Sabouraud
dextrose (Sabdex) agar plates (1% [wt/vol] mycological peptone, 4% [wt/vol] glucose, and 2% [wt/vol]
agar). Strain SC5314 (serotype A) and the genetically derived CAI-4 were used predominantly in TEM
imaging experiments. A range of isogenic mutants (created in the CAI-4 background) with disruptions in
their cell wall were also examined, including mutants with defects in outer chain N-mannosylation
(och1Δ, NGY357) (27), O-mannosylation (mnt1Δ mnt2Δ, NGY337) (48), or phosphomannan biosynthesis
(mnn4Δ, CDH15) (49) or mutants downregulated in glycosylation due to low levels of Mn2 in the Golgi
complex (pmr1Δ, NGY355) (49). The chs3Δ strain was provided by Christine Bulawa (50), and the
C. albicans and C. tropicalis erg3Δ and erg11Δ mutants were gifts from Dominique Sanglard (51).
C. albicans strains were ﬁrst grown overnight in orbital shake ﬂask cultures at 200 rpm at 30°C in
Sabouraud broth (1% [wt/vol] mycological peptone, 4% [wt/vol] glucose) and then inoculated into fresh
AmBisome Transit through Fungal Cell Walls ®
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RPMI 1640 medium for 1 h at 37°C in the presence of 12 g/ml AmBisome prior to harvesting for TEM.
A short exposure to AmBisome of only 1 h was chosen to allow AmBisome to be observed in the early
stages of entry into the cell. By this time, there was no measurable effect on cell viability or membrane
damage. For the same reasons, AmBisome was added to cells for 1 h prior to the HPF-TEM and porosity
assays described below.
High-pressure freezing–freeze substitution transmission electron microscopy. C. albicans yeast
cells were ﬁrst grown in RPMI 1640 in the presence of 12 g/ml AmBisome for 1 h, before extensive
fungal cell lysis took place, and then pelleted and washed with sterile H2O. This super-MIC of AmBisome
was chosen in order to be able to image sufﬁcient liposome in single serial sections and tomograms. The
AmBisome-treated yeast cells were snap-frozen in liquid nitrogen at high pressure using a Leica Empact
high-pressure freezer (Leica, Milton Keynes, United Kingdom). The frozen samples were then ﬁxed in an
automatic temperature-controlled Leica AFS freeze substitution system in dried acetone containing 2%
(wt/vol) OsO4, 1% (wt/vol) uranyl acetate, 1% (vol/vol) methanol, and 5% (vol/vol) water in acetone at
90°C for 48 h (52). Samples were then warmed to 30°C and processed in a Lynx tissue processor with
1:2 acetone-resin and embedding in TAAB812 (TAAB Laboratories, Aldermaston, United Kingdom) epoxy
resin. One-hundred-nanometer sections were cut with a Leica Ultracut E microtome and stained with
uranyl acetate and lead citrate. Samples were examined using a Philips CM10 transmission microscope
(FEI UK Ltd., Cambridge, United Kingdom), and images were captured using a Gatan BioScan 792 camera
system (Gatan UK, Abingdon, United Kingdom). The average thicknesses of the inner and outer cell wall
layers were measured using ImageJ for 20 measurements for each strain.
For C. neoformans studies, C. neoformans yeast cells were similarly grown in a deﬁned minimal
medium (29.4 mM KH2PO4, 10 mM MgSO4, 13 mM glycine, 15 mM dextrose, and 3 M thiamine-HCl) at
30°C to mid-exponential phase. Samples were then high-pressure frozen using a Bal-Tec HPM 010
high-pressure freezer (Boeckler Instruments, Tucson, AZ). Frozen samples were transferred to an RMC
FS-7500 freeze substitution unit (Boeckler Instruments, Tucson, AZ) and freeze substituted in 2% osmium
tetroxide, 1% uranyl acetate, 1% methanol, and 5% water in acetone. They were brought from 90°C to
room temperature over 2 to 3 days, rinsed in acetone, and embedded in LX112 epoxy resin (Ladd Inc.,
Burlington, VT). Ultrathin sections of 70 to 80 nm were cut on a Leica Ultracut UC7 microtome, stained
with uranyl acetate followed by lead citrate, and viewed on a JEOL 1200EX transmission electron
microscope at 80 kV.
Electron tomography. The C. albicans specimens prepared as described above for TEM were also
employed for tomography. Thicker sections (225 nm) were cut using a Leica UC6 ultramicrotome (Leica
Microsystems GmbH) onto 200-mesh copper grids and stained with uranyl acetate and lead citrate.
Single-axis tilt series of multiple regions of the C. albicans cell wall were captured using a JEM-1400 Plus
transmission electron microscope (JEOL Ltd., Japan) set at 120 kV and equipped with a bottom-mounted
Gatan SC1000 Orius charge-coupled device (CCD) camera (Gatan, USA). After background correction,
adjustment of tilt eccentricity, and image calibration, tilts were recorded at an 20,000 magniﬁcation
and a 10,000-pixel maximum, between 68° and 68° at 0.5° intervals set by goniometric control with
focus readjustment every 4°. The tilt series were acquired by JEOL TEM Recorder v2.7 and TEM Centre for
JEM-1400 Plus (JEOL Ltd., Japan).
Preparation of liposome reagents. Hydrogenated soy phosphatidylcholine (HSPC), cholesterol,
distearoylphosphatidylglycerol (DSPG), amphotericin B, and alpha-tocopherol were dissolved in a 2:1:
0.8:0.4:0.01 molar ratio in a 1:1 mixture of methanol and chloroform (or, for some liposomes, the same
formula without amphotericin B). Once all components were dissolved, solvents were removed by
evaporation under continuous nitrogen ﬂow. Residual solvent was removed by storing the container
containing the material in a desiccator under vacuum for at least 48 h. The dried lipid was hydrated in
a buffer containing 9% sucrose and 10 mM succinate at the desired drug concentrations, and the
hydrated material was processed through a high-shear homogenizer to form liposomes. For encapsu-
lation of conjugated spherical gold nanoparticles (15-nm methyl polymer-conjugated gold nanoparticles;
Nanopartz, Inc., Loveland, CO, USA), the buffer was spiked with the nanoparticles during the beginning
of hydration. Nonentrapped gold was removed by centrifugation. For samples prepared with ~1.6-nm
gold particles associated with the bilayers, dipalmitoyl phosphatidylethanolamine (DPPE) Nanogold
(Nanoprobes, Yaphank, NY) was added to the lipid mixture noted above and included in the preparation
of dried lipid. The quantities used reﬂected up to about 10 gold moieties per liposome particle.
Liposomes were then prepared as described above. For both types, samples were conﬁrmed to have a
median particle size of ~80 nm by dynamic light scattering. Amphotericin B concentration was conﬁrmed
by reversed-phase high-pressure liquid chromatography (HPLC) using a C18 column and isocratic elution
against acetonitrile-methanol-2.5 mM EDTA (25:50:30 [vol/vol/vol]) and using the USP standard.
Cell wall permeability assay. C. albicans strains were grown overnight at 200 rpm at 30°C in
Sabouraud broth (1% mycological peptone-4% glucose) and then washed with sterile H2O and inocu-
lated into fresh RPMI 1640 medium for 1 h at 37°C in the presence of 12 g/ml AmBisome before carrying
out the porosity assay. Measurements of the porosity of the C. albicans cell wall used the polycationic
polymers DEAE-dextran and poly-L-lysine (PLL). These reagents enhance the permeability of the cell
membrane, resulting in the leakage of cytosol and nucleic acids (12, 14). Yeast cells were centrifuged and
washed three times with double-distilled water (ddH2O), and 1  108 cells/ml were resuspended in
10 mM Tris-HCl (pH 7.4) containing 10 g/ml of PLL (molecular mass, 30 to 70 kDa; Sigma) or 5 g/ml
of DEAE-dextran (molecular mass, 500 kDa; Sigma) and incubated at 30°C for 30 min with shaking at
200 rpm. The release of UV-absorbing compounds was determined by measuring the A260 of cell-free
supernatant. The supernatant from cells in Tris-HCl buffer with no polycationic polymer was used as a
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control. The relative cell wall porosity was deﬁned as relative cell wall porosity (%)  [(A260 of
DEAE-dextran  A260 of buffer)/(A260 of PLL  A260 of buffer)]  100.
Antifungal susceptibility testing. A modiﬁed microtiter dilution assay (CLSI method M27) was used
to test for the MIC of AmBisome for the various C. albicans cell wall mutants, using the indicator dye
alamarBlue. Brieﬂy, the yeast cell count was adjusted to a ﬁnal concentration of 2  104 cells/ml in
RPMI-morpholinepropanesulfonic acid (RPMI-MOPS). Aliquots of 100 l/well of a series of 2-fold dilutions
of each drug in RPMI-MOPS (0.08 to 40 g/ml) were dispensed into triplicate wells of a 96-well
ﬂat-bottom microtiter plate, with aliquots (100 l/well) of the yeast suspension dispensed into each test
well and 20 l of alamarBlue dispensed into each well. The plate was incubated at 35°C for 48 h. The MIC
was the lowest concentration of drug showing inhibition of growth based on spectrophotometric
readings at 570 to 600 nm on a SpectraMax microplate reader (53).
For C. albicans viability assays, stationary-phase yeast cells were inoculated to an optical density at
600 nm (OD600) of 0.1 and incubated at 30°C with shaking. At each time point, 25-l volumes of culture
were sampled and serially diluted in sterile ddH2O to generate suspensions containing 1  106, 1  105,
1  104, 1,000, 100, and 10 cells/ml. Dilutions were spotted onto YPD agar plates and incubated
overnight at 30°C. After incubation, the number of colonies was counted and used to determine the
viability of each strain over time.
IC50 measurements were determined by broth microdilution testing using the CLSI M27-A3 guide-
lines. The concentration of AmBisome at which the growth of each strain was inhibited by 50% (IC50) in
YPD for 24 h at 30°C was calculated from the MIC curves.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.02383-17.
FIG S1, TIF ﬁle, 2 MB.
MOVIE S1, AVI ﬁle, 16 MB.
MOVIE S2, AVI ﬁle, 16 MB.
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